Aru-18

About Aru-18

Aru-18 — Chebulic Eighteen, A-ru bco-brgyad — is a classical Sowa Rigpa kidney and urinary-tract formula. It belongs to the chebula family of compounds (Chebula-7, 10, 18, 23, 25, and 35), each of which extends the action of chebulic myrobalan (a-ru-ra, Terminalia chebula) to a specific organ terrain. Aru-7 carries the chebulic virtue to the spleen; Aru-10 to kidney stones and urolithiasis; Aru-18 to kidney inflammation, waist and hip pain of kidney-channel origin, and the chronic urinary disturbances that follow cold or mixed patterns in the lower back.

In Tibetan pharmacology a-ru-ra is sman-gyi rgyal-po, the king of medicines — the drug the rGyud-bzhi and the Bdud-rtsi-snying-po give first place. Iconographically, the Medicine Buddha holds the myrobalan branch in his right hand, with the begging bowl of nectar (bdud-rtsi) cradled in his left. The seven classical varieties of a-ru-ra — rnam-par-rgyal-ba (Victory), bum-gyi-mgrin (Vase-neck), gso-byed (Healing), bdud-rtsi (Nectar), 'jigs-med (No-fear), phel-byed (Increaser), and skam-po (Dry) — are distinguished by shape and therapeutic emphasis, with Victory and Nectar most esteemed. The name bco-brgyad reads as ten-eight = eighteen; bco is a euphonic contraction of bcu (ten) that appears when ten is compounded with the smaller numerals.

Published recensions (Medicine Traditions' Tibetan Formula Families; Dhakal et al. 2021; Natural Remedies Center; Tsarong's Handbook of Traditional Tibetan Drugs) converge on an eighteen-ingredient build centered on chebulic myrobalan and surrounded by kidney-channel cooling, moving, and binding drugs. The exact roster varies modestly across Men-Tsee-Khang, Chagpori, and Bhutanese lineages. The principal components recur: safflower, madder, caesalpinia, Himalayan cypress, cardamom, jambolana, mallow, mucuna, swertia, symplocos, mullein, and crabshell among them.

Aru-18 works on mkhal-ma (kidneys), gcin (urine), and the chu-sder channel network of the lower back. Its therapeutic signature is the pacification of cold Bad-kan settled into the kidney seat together with the rLung disturbance that such cold produces in the lower back, hips, and urinary holding. Where there is stagnation in the urinary channels with gravel, crabshell and madder in the formula move and bind the residue; where there is inflammation without bleeding, swertia and cypress cool; where there is weak kidney-rLung that fails to hold gcin, mucuna, cardamom, and the lineage-specific warming anchor steady the downward tone. The compound is a pacifier and regulator more than a tonic: it addresses kidney-channel imbalance, not kidney essence depletion, and it is given in courses rather than indefinitely.

A named sub-variant, Gcin-snyi a-ru bco-brgyad, is prescribed specifically for urinary incontinence. The base eighteen-ingredient architecture is retained, with the proportion of kidney-rLung anchoring herbs adjusted upward so that the formula holds gcin in elderly, post-partum, and post-surgical presentations of weak lower-back tone. This sub-variant sits alongside the general Aru-18 in most Men-Tsee-Khang pharmacopoeiae.

In classical Sowa Rigpa seasonal correspondence, the emphasis for Aru-18 is autumn into winter, when kidney-essence complaints and bone-marrow cold surface. Constitutionally it matches elderly patients with chronic lumbar weakness, post-partum recoveries where the lower back has not returned to tone, and Bad-kan-rLung mixed presentations with cold hips, irregular urination, and fatigue that concentrates in the lower half of the body.

Ingredients

Eighteen ingredients, centered on chebulic myrobalan and rounded out with kidney-channel cooling, moving, and binding drugs. Ingredient rosters vary modestly across lineages; the principal components recur:

Preparation

The myrobalan fruits are cleaned, pitted, sun-dried, and ground. Flowers and bitter-cooling leaves (safflower, swertia, madder, mallow) are dried and ground separately to preserve their active constituents. Aromatic seeds (cardamom) are ground last to retain volatile oils. Crabshell is calcined and powdered. Components are blended in the textual proportion, moistened with a water-honey binder, rolled into small ril-bu, and slow-dried. For the classical decoction form, the coarse-ground blend is simmered in water until reduced by half and strained before use.

Indications

Contraindications

Use with caution in pregnancy — madder and some of the moving ingredients are traditionally contraindicated for gravid patients. Avoid in acute febrile kidney disease with frank bleeding. Where crabshell or madder are present at full proportion, use caution alongside pharmaceutical anticoagulants and consult a practitioner. Very weak digestive fire may require a short course of a warming digestive formula before Aru-18 is tolerated. Not a substitute for acute care in pyelonephritis with high fever.

Dosage

Pill form: 2–3 ril-bu twice daily with warm water, typically taken in the late morning and afternoon. Decoction form: approximately one cup of the strained decoction twice daily. Courses commonly run 3–6 weeks for kidney-channel presentations; longer courses, staged with rest weeks, are used in chronic lumbar weakness and in the incontinence sub-variant. Reassess by pulse and urine examination at the end of each course.

Significance

Aru-18 is the chebulic-family expression of kidney and urinary-tract medicine. Where Aru-7 carries a-ru-ra into the spleen and Aru-10 into the stone-forming seat of the kidney, Aru-18 extends the same chebulic foundation to kidney-channel inflammation, waist and hip pain, and urinary regulation. The formula therefore sits at the intersection of two fundamental elements of Sowa Rigpa: the primacy of a-ru-ra as sman-gyi rgyal-po, the king of medicines held in the Medicine Buddha's right hand, and the organ-specific elaboration of the chebula family across the Tibetan pharmacopoeia. In lineage teaching, Aru-18 is one of the foundational kidney formulas a practitioner learns before moving to the more specialized lower-back and essence compounds.

Ayurvedic Parallel

The Ayurvedic parallel lies in the mutra-vaha srotas family of formulas rather than in Triphala. Chandraprabha Vati, Gokshuradi Guggulu, Punarnavadi Kwath, and Varunadi Kwath occupy similar therapeutic ground for kidney-urinary complaints, with haritaki (Terminalia chebula) — the same drug that anchors Aru-18 — appearing as a supporting ingredient in several of these Ayurvedic preparations. Triphala remains the most recognizable cross-tradition haritaki formula, but its therapeutic axis is different: Triphala is a general bowel-and-eye tonic, while Aru-18 targets the kidney channels specifically.

TCM Parallel

The nearest Traditional Chinese Medicine parallels are the kidney formulas rather than the spleen-stomach digestives. Liu Wei Di Huang Wan (six-flavor kidney-yin) addresses the yin-deficient substrate beneath chronic kidney inflammation; Ji Sheng Shen Qi Wan (kidney-yang with fluid retention) addresses the cold-pattern retention that Aru-18 also treats; Ba Zheng San addresses damp-heat lin (painful urination) syndromes; and Suo Quan Wan is a direct parallel for the incontinence sub-variant Gcin-snyi a-ru bco-brgyad. The chebulic myrobalan base has no close TCM equivalent — it is a Himalayan drug that the Tibetan and Ayurvedic traditions share and that the Chinese tradition incorporates only in border-region pharmacopoeiae.

Connections

Within the chebula family: Aru-7 (spleen), Aru-10 (kidney stones and urolithiasis), Aru-23, Aru-25, and Aru-35 extend the chebulic foundation to other organ territories. Cross-tradition anchor: the Terminalia chebula / haritaki materia medica. Companion Tibetan formulas: shilajit-bearing (brag-zhun) compounds for kidney-essence support, and external therapies at the kidney moxibustion points on the lower back. For cross-tradition context, the Ayurvedic Chandraprabha Vati and the Chinese Liu Wei Di Huang Wan occupy related terrain.

Further Reading